News + Filings Transactions Holdings
|
Hindson Benjamin J.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/22/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 3.4k | $45.78 | $157.9k | | 08/22/2023 |
| 08/01/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 1.7k | $61.77 | $106.7k | | 08/01/2023 |
| 08/01/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 5.2k | $62.36 | $326.9k | | 08/01/2023 |
| 08/01/2023 | 10x Genomics, Inc. | TXG | Exercise | Stock Option (right to buy) | 7k | $11.48 | $80k | | 08/01/2023 |
| 05/23/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 243 | $55.06 | $13.4k | | 05/23/2023 |
| 05/23/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 619 | $55.06 | $34.1k | | 05/23/2023 |
| 05/23/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 735 | $55.06 | $40.5k | | 05/23/2023 |
| 05/23/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 791 | $55.06 | $43.6k | | 05/23/2023 |
| 03/21/2023 | 10x Genomics, Inc. | TXG | Grant | Class A Common Stock | 36.4k | $0.00 | $0 | | 03/21/2023 |
| 03/21/2023 | 10x Genomics, Inc. | TXG | Grant | Stock Option (right to buy) | 36.4k | $50.10 | $1.8M | | 03/21/2023 |
| 03/21/2023 | 10x Genomics, Inc. | TXG | Grant | Performance- based Restricted Stock Units | 18.2k | $0.00 | $0 | | 03/21/2023 |
| 02/22/2023 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 1.7k | $47.75 | $83.2k | | 02/22/2023 |
| 12/14/2022 | 10x Genomics, Inc. | TXG | Exercise | Stock Option (right to buy) | 34.3k | $5.04 | $172.7k | | 12/14/2022 |
| 11/22/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 359 | $34.07 | $12.2k | | 11/22/2022 |
| 11/22/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 915 | $34.07 | $31.2k | | 11/22/2022 |
| 11/22/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 1.1k | $34.07 | $37k | | 11/22/2022 |
| 09/14/2022 | 10x Genomics, Inc. | TXG | Grant | Class A Common Stock | 33.8k | $0.00 | $0 | | 09/14/2022 |
| 09/14/2022 | 10x Genomics, Inc. | TXG | Grant | Stock Option (right to buy) | 67.7k | $33.67 | $2.3M | | 09/14/2022 |
| 09/14/2022 | 10x Genomics, Inc. | TXG | Grant | Performance-based Restricted Stock Units | 67.7k | $0.00 | $0 | | 09/14/2022 |
| 08/23/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 1.3k | $35.19 | $45.5k | | 08/23/2022 |
| 05/23/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 1.3k | $48.76 | $61.6k | | 05/23/2022 |
| 03/22/2022 | 10x Genomics, Inc. | TXG | Grant | Stock Option (Right to Buy) | 71.2k | $69.56 | $5M | | 03/22/2022 |
| 03/22/2022 | 10x Genomics, Inc. | TXG | Grant | Class A Common Stock | 28.5k | $0.00 | $0 | | 03/22/2022 |
| 02/22/2022 | 10x Genomics, Inc. | TXG | Gift | | 133.5k | $0.00 | $0 | See footnote | 02/22/2022 |
| 02/22/2022 | 10x Genomics, Inc. | TXG | Gift | | 133.5k | $0.00 | $0 | See footnote | 02/22/2022 |
| 02/22/2022 | 10x Genomics, Inc. | TXG | Gift | | 267k | $0.00 | $0 | See footnote | 02/22/2022 |
| 02/22/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 360 | $78.59 | $28.3k | | 02/22/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 2.3k | $144.56 | $332.5k | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 16.5k | $145.43 | $2.4M | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 17.4k | $146.29 | $2.5M | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 2.9k | $147.34 | $428.2k | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 2k | $148.44 | $296.9k | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Sale | Class A Common Stock | 600 | $149.24 | $89.5k | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Exercise | Stock Option (right to buy) | 2.1k | $11.48 | $23.9k | | 01/03/2022 |
| 01/03/2022 | 10x Genomics, Inc. | TXG | Exercise | Stock Option (right to buy) | 39.6k | $74.58 | $3M | | 01/03/2022 |
|
|